| Lillian Merrill Gates, OTR/L | |
|
2000 Ministerial Rd, Wakefield, RI 02879-1318 | |
| (401) 741-8056 | |
| Not Available |
| Full Name | Lillian Merrill Gates |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2000 Ministerial Rd, Wakefield, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003598905 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT02185 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lillian Merrill Gates, OTR/L 2000 Ministerial Rd, Wakefield, RI 02879-1318 Ph: (401) 741-8056 | Lillian Merrill Gates, OTR/L 2000 Ministerial Rd, Wakefield, RI 02879-1318 Ph: (401) 741-8056 |
News Archive
Existing scientific literature suggests the U.S. government nutritional program known as WIC improves birth outcomes of children, but new research is unable to find either a positive or negative impact on infant health.
Recent outbreaks of emerging diseases such as SARS and H5N1 avian influenza have underlined the fact that animal pathogens may acquire the ability to spread efficiently in humans but as yet have not.
Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities, recently characterized a broad spectrum of facial and brain anomalies in individuals with chromosome aberrations associated with holoprosencephaly.
Almost half of the recent 16000 staff expansion of the NHS came from the recruitment of health professionals trained outside the UK and Europe, states an article in this week's issue of The Lancet.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox® (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox®.
› Verified 6 days ago
Leslie Healy, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12 Galleon Ct, Wakefield, RI 02879 Phone: 401-783-0322 | |
Amy Ciesynski O'brien, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 10 High St, Wakefield, RI 02879 Phone: 401-783-8077 Fax: 401-789-6029 | |
May Morris, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 213 Robinson St, Wakefield, RI 02879 Phone: 401-284-1000 | |
Lori Ann Wheeler, OTR/L, CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 10 High St, Wakefield, RI 02879 Phone: 401-777-7000 | |
Crystal Dubowski, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 585 Kingstown Rd, Wakefield, RI 02879 Phone: 401-284-4357 | |
Ms. Tia Beckman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 43a Cherry Ln, Wakefield, RI 02879 Phone: 401-782-1060 |